Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Veracyte (VCYT) Gross Margin (2016 - 2025)

Veracyte's Gross Margin history spans 14 years, with the latest figure at 72.51% for Q4 2025.

  • For Q4 2025, Gross Margin rose 612.0% year-over-year to 72.51%; the TTM value through Dec 2025 reached 70.1%, up 322.0%, while the annual FY2025 figure was 70.1%, 322.0% up from the prior year.
  • Gross Margin for Q4 2025 was 72.51% at Veracyte, up from 69.22% in the prior quarter.
  • Across five years, Gross Margin topped out at 72.98% in Q3 2023 and bottomed at 55.6% in Q1 2021.
  • The 5-year median for Gross Margin is 67.04% (2021), against an average of 66.77%.
  • The largest annual shift saw Gross Margin surged 1600bps in 2021 before it plummeted -526bps in 2023.
  • A 5-year view of Gross Margin shows it stood at 67.01% in 2021, then increased by 4bps to 69.95% in 2022, then decreased by -6bps to 65.98% in 2023, then rose by 1bps to 66.39% in 2024, then rose by 9bps to 72.51% in 2025.
  • Per Business Quant, the three most recent readings for VCYT's Gross Margin are 72.51% (Q4 2025), 69.22% (Q3 2025), and 68.97% (Q2 2025).